INDUSTRY EXPERT ARTICLES

Brian Pedlar, CEO of Covalon Technologies writes, A simple dressing application holds the power to both heal and harm. However, beneath their seemingly straightforward design exists a realm of concerns. When the wrong dressing is used it can cause significant harm affecting everyone from the tiniest of babies in the NICU to vulnerable adults, clinicians, caregivers, and even hospital administration.” Read more what he has to say.

Harvey writes, “When we looked at cybersecurity and medical devices last fall, the Food and Drug Administration (FDA) did not have express federal statutory requirements for medical device manufacturers regarding cybersecurity. However, it is clear that there are real dangers. In September 2022, the Federal Bureau of Investigation (FBI) reported that as of January 2022, 53% of connected medical devices and other Internet of things (IoT) devices in hospitals had known critical vulnerabilities.” Read on.

Christopher Cauble writes, “There are many risks and a few rewards to an intellectual property strategy that foregoes patent protection in non-U.S. jurisdictions. Startups or midsize medical device companies should include intellectual property specialists in strategy sessions for market development.” Read to learn more.

Luka Yancopoulos writes: “There’s a lingering issue in the healthcare sector that doesn’t get the attention it deserves, and it’s not directly related to patient care or medication breakthroughs. Instead, it revolves around the supply chain – the backbone of the healthcare industry that ensures critical medical supplies get from manufacturers to end-users.” Read on to learn more.

Sparrow BioAcoustics is a medical software startup in Newfoundland, Canada. The company has ties to the people of Ukraine, both through our staff and our connections with Ukrainian doctors and engineers who have helped the company refine our initial prototypes into a viable clinical-grade product. Helping the people of Ukraine is one of our corporate priorities. Read on.

Jess Harris writes: “The benefits that 3D printing presents today are numerous, but with these opportunities come associated challenges. As technology continues to advance at a remarkable pace, the life science industry must closely consider the resulting risks, and regulatory frameworks must adapt to ensure that the benefits outweigh the liabilities.” Read on.